Skip to content Skip to footer
team-zimmerman

M.D., PhD.

Dr. Maximo Zimerman

Dr. Zimerman is a trained Neurologist. In 2007, he received the “Deutscher Akademischer Austausch Dienst (DAAD)” scholarship to complete his PhD.

Argentina

Biography

Dr. Zimerman is a trained Neurologist. In 2007, he received the “Deutscher Akademischer Austausch Dienst (DAAD)” scholarship to complete his PhD. in the Brain Imaging and NeuroStimulation laboratory at the University Medical Center Hamburg-Eppendorf, Germany.

Within this period, different projects were concluded focusing on the mechanisms underlying plastic changes in the human central nervous system and in the development of novel therapeutic approaches for recovery of function based on the understanding of these mechanisms in stroke. In 2011, he received the “Young Research Award (FFM)” from the University of Hamburg for a project focusing on understanding the mechanisms underlying motor learning in healthy conditions and in stroke patients.

In 2012, he received the title of Doctor in Neuroscience by the University of Hamburg with the result of “Summa cum laude”.

His responsibility is the treatment of patients in the stroke and spasticity outpatient’s clinic, a multidisciplinary program dedicated to the aftermath of stroke at the University Medical Center Hamburg-Eppendorf. In parallel, he finished his postdoctoral fellow in the field of neuroplasticity and motor recovery strategies after brain injury. Recently, he moved back to Argentina and is the Medical director of CITES-INECO, a Neurorehabilitation and interdisciplinary clinic located in Buenos Aires.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.